Consistent with results of in vitro cytotoxicity assays, both dPD1z T and CARPD-L1z T cells inhibited the growth of H460GL cells in immunodeficient NSI (NOD/SCID/IL-2 g−/−) mice [42, 43], and CARPD-L1z T cells showed superior anti-tumor effects (Fig. 2a-b). The gene discussed is IL2; the disease is neoplasm.